Great Lakes Advisors’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.49M	Sell	71,043 -2,923	-4%	-$259K	0.06%	177
2025 Q4	$6.46M	Sell	73,966 -15,205	-17%	-$1.24M	0.05%	197
2025 Q3	$5.92M	Sell	89,171 -50,220	-36%	-$2.85M	0.05%	224
2025 Q2	$7.7M	Sell	139,391 -12,927	-8%	-$620K	0.06%	226
2025 Q1	$7.37M	Buy	152,318 +90,371	+146%	+$3.79M	0.07%	223
2024 Q4	$2.39M	Sell	61,947 -7,678	-11%	-$335K	0.02%	457
2024 Q3	$3.13M	Sell	69,625 -23,854	-26%	-$964K	0.03%	421
2024 Q2	$3.24M	Sell	93,479 -3,681	-4%	-$108K	0.03%	405
2024 Q1	$2.81M	Buy	97,160 +6,007	+7%	+$163K	0.02%	428
2023 Q4	$2.09M	Sell	91,153 -50,406	-36%	-$882K	0.02%	454
2023 Q3	$2.36M	Sell	141,559 -5,489	-4%	-$107K	0.02%	439
2023 Q2	$4.06M	Sell	147,048 -3,436	-2%	-$86K	0.04%	367
2023 Q1	$3.46M	Buy	+150,484	New	+$2.53M	0.03%	427